Kyla Mckay
Assistant Professor
E-mail: kyla.mckay@ki.se
Visiting address: Eugeniahemmet, Maria Aspmans gata 30 A, 17176 Stockholm
Postal address: K8 Klinisk neurovetenskap, K8 Neuro Fink/McKay, 171 77 Stockholm
About me
- Assistant Professor of Neuroepidemiology
Epidemiologist with a PhD from the University of British Columbia and
postdoctoral training at the Karolinska Institute. My research focuses
largely on the causes and consequences of multiple sclerosis.
*Assistant Professorship* - Karolinska Institutet - April 2023 to April 2028
*Forte Postdoctoral Award - *Swedish Research Council for Health, Working
Life and Welfare – January 2020 to 2022
*endMS Postdoctoral Fellowship Award - *Multiple Sclerosis Society of Canada
– September 2020 to 2021 (declined)
*Forskningsbidrag (R**esearch Grant) - *Svenska MS-Sällskapet (Swedish
MS Association) – January 2020
*Karolinska Institutet Internship Program - *Försvarsmakten (Swedish Armed
Forces) – August 2019 to October 2019
*Early-career investigator scholarship *- Columbia University, USA – May
2019
*Forskningsanslag (Research grant)* - Neuroförbundet – January 2018 to
December
2019
*Postdoctoral Research Fellowship Exchange Award - *European Committee for
Treatment and Research in Multiple Sclerosis (ECTRIMS) – September 2017 to
2019
*Postdoctoral Fellowship Award * - Canadian Institutes of Health Research
– September 2017 to 201
*PhD* in Experimental Medicine - University of British Columbia, Vancouver,
British Columbia, Canada (June 2017)
Dissertation: /Using linked health data to investigate the epidemiology and
impact of mental health and health behaviours in multiple sclerosis/
*Bachelor of Science* – Major in Neuroscience - Dalhousie University,
Halifax, Nova Scotia, Canada (May 2008)
Research
- Multiple sclerosis (MS) is a chronic, progressively disabling disease of the
central nervous system. Its aetiology is not fully understood and it has no
known cure. Between 3 and 10% of persons with MS experience their first
neurological symptoms in childhood. Though paediatric MS accounts for a small
percentage of all cases, it is particularly distressing to patients and their
families. Few population-based studies have investigated the demographic and
clinical characteristics of MS in children, which contributes to uncertainty
in the management of the disease.
My research focuses on better understanding what causes paediatric multiple
sclerosis. We believe that a focus on this cohort of patients will help us
understand the aetiology of disease in the wider MS population. Our research
capitalizes on the wealth of population-based health data available in
Sweden.
Articles
- Journal article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2024;92:105943
- Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2024;11(6):1393-1404
- Article: EUROPEAN JOURNAL OF NEUROLOGY. 2024;31(5):e16253
- Article: NEUROLOGY. 2024;102(6):e208051
- Article: ANNALS OF NEUROLOGY. 2024;95(3):487-494
- Article: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. 2024;95(3):229-234
- Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2024;53(1):dyad184
- Article: FRONTIERS IN PUBLIC HEALTH. 2024;12:1331746
- Article: JAMA NETWORK OPEN. 2023;6(9):e2334675
- Article: NEUROLOGY. 2023;101(5):e522-e532
- Article: MULTIPLE SCLEROSIS JOURNAL. 2023;29(9):1126-1135
- Article: MULTIPLE SCLEROSIS JOURNAL. 2023;29(6):731-740
- Article: JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY. 2023;94(4):284-289
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:e198
- Article: MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL, TRANSLATIONAL AND CLINICAL. 2022;8(4):20552173221144230
- Article: ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2022;9(9):1449-1458
- Journal article: INTERNATIONAL JOURNAL OF POPULATION DATA SCIENCE. 2022;7(3):1804
- Article: MULTIPLE SCLEROSIS JOURNAL. 2022;28(7):1051-1059
- Journal article: NEUROLOGY. 2022;98(18_supplement)
- Article: ANNALS OF NEUROLOGY. 2022;91(3):417-423
- Article: ACTA NEUROLOGICA SCANDINAVICA. 2021;144(6):680-686
- Article: SCIENTIFIC REPORTS. 2021;11(1):18528
- Journal article: NEUROLOGY. 2021;96(15_supplement)
- Article: JAMA NEUROLOGY. 2021;78(4):478-482
- Article: NEUROLOGY: NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2020;7(6):e903
- Article: NEUROLOGY. 2020;94(9):e932-e941
- Article: NEUROLOGY. 2019;93(24):e2216-e2223
- Article: JAMA NEUROLOGY. 2019;76(9):1028-1034
- Article: NEUROLOGY. 2019;92(24):e2764-e2773
- Article: JOURNAL OF NEUROLOGY. 2019;266(2):481-486
- Article: NEUROLOGY. 2018;90(15):e1316-e1323
- Journal article: INTERNATIONAL JOURNAL OF MS CARE. 2018;20(2):76-84
- Journal article: NEUROEPIDEMIOLOGY. 2018;51(1-2):1-10
- Article: NEUROLOGY. 2017;89(24):2455-2461
- Article: NEUROTOXICOLOGY. 2017;61:243-264
- Article: MULTIPLE SCLEROSIS JOURNAL. 2017;23(4):588-596
- Article: INTERNATIONAL JOURNAL OF POPULATION DATA SCIENCE. 2017;86(1):28
- Article: NEUROEPIDEMIOLOGY. 2017;48(3-4):124-130
- Article: EUROPEAN JOURNAL OF NEUROLOGY. 2016;23(6):1093-1100
- Article: NEUROLOGY. 2016;86(15):1417-1424
- Journal article: NEUROLOGY. 2016;86(16_supplement)
- Article: MULTIPLE SCLEROSIS JOURNAL. 2016;22(5):685-693
- Article: INTERNATIONAL JOURNAL OF MS CARE. 2016;18(2):96-104
- Article: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2015;4(5):470-476
- Journal article: NEUROLOGY. 2015;84(14_supplement)
- Show more
All other publications
- Letter: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2024;88:105726
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:202-203
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:1045-1046
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:429-430
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:11-12
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:777
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:173-174
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:169-170
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2023;29:1083-1084
- Review: BMC MEDICINE. 2022;20(1):251
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):438
- Editorial comment: MULTIPLE SCLEROSIS JOURNAL. 2022;28(1):3-6
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):178-179
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):169-170
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):212
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2022;28(3_SUPPL):460
- Letter: JAMA NETWORK OPEN. 2021;4(12):e2136697
- Preprint: SSRN ELECTRONIC JOURNAL. 2021
- Book chapter: NEUROIMMUNOLOGY. 2021;p. 137-153
- Conference publication: NEUROLOGY. 2021;96(15)
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):763-764
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):60-61
- Review: ACTA NEUROLOGICA SCANDINAVICA. 2021;143(1):39-50
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):257
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2020;26(3_SUPPL):137-138
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:396-397
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:375-376
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:693
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:406-407
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:540-541
- Review: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2018;20:169-177
- Review: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(2):133-139
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:542
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:41
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:665-666
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:469-470
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2018;24:544
- Review: NEUROTOXICOLOGY. 2017;61:266-289
- Review: NEUROTOXICOLOGY. 2017;61:189-212
- Editorial comment: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2017;12:1-3
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:25
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2017;23:991
- Conference publication: NEUROLOGY. 2016;86
- Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:339-340
- Review: MULTIPLE SCLEROSIS AND RELATED DISORDERS. 2016;5:53-65
- Editorial comment: LANCET NEUROLOGY. 2015;14(3):237-238
- Review: BIOMED RESEARCH INTERNATIONAL. 2015;2015:817238-11
- Show more
Grants
- Swedish Research Council for Health Working Life and Welfare1 January 2020 - 31 December 2021
- Swedish Research Council1 January 2019 - 31 December 2021
- The causes and consequences of paediatric multiple sclerosis: A population-based studyCanadian Institutes of Health Research1 September 2017 - 31 December 2020
- Using linked health data to investigate the impact of psychiatric comorbidity on disability progression in multiple sclerosisCanadian Institutes of Health Research1 May 2016 - 5 July 2017